Shares of Streamline Health Solutions Inc. (NASDAQ:STRM) have been assigned a consensus broker rating score of 2.00 (Buy) from the two brokers that provide coverage for the stock, Zacks Investment Research reports. One analyst has rated the stock with a hold rating and one has assigned a strong buy rating to the company. Streamline Health Solutions’ rating score has declined by 19.8% from three months ago as a result of various analysts’ upgrades and downgrades.
Brokerages have set a 12 month consensus price objective of $5.00 for the company and are anticipating that the company will post ($0.07) earnings per share for the current quarter, according to Zacks. Zacks has also assigned Streamline Health Solutions an industry rank of 112 out of 265 based on the ratings given to related companies.
Separately, Zacks Investment Research upgraded shares of Streamline Health Solutions from a “hold” rating to a “buy” rating and set a $1.50 price target on the stock in a research note on Wednesday, June 22nd.
Shares of Streamline Health Solutions (NASDAQ:STRM) opened at 1.90 on Friday. Streamline Health Solutions has a 52-week low of $1.08 and a 52-week high of $2.32. The stock’s market capitalization is $37.60 million. The firm’s 50-day moving average is $1.63 and its 200 day moving average is $1.42.
Streamline Health Solutions (NASDAQ:STRM) last issued its quarterly earnings results on Wednesday, September 7th. The company reported ($0.06) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.08) by $0.02. The business had revenue of $7.40 million for the quarter, compared to analysts’ expectations of $7.02 million. Streamline Health Solutions had a negative net margin of 14.77% and a negative return on equity of 26.31%. Equities analysts expect that Streamline Health Solutions will post ($0.31) EPS for the current year.
In other Streamline Health Solutions news, SVP Shaun Linwood Priest purchased 23,400 shares of the company’s stock in a transaction dated Monday, September 19th. The shares were acquired at an average price of $1.66 per share, for a total transaction of $38,844.00. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 12.60% of the company’s stock.
Several hedge funds have recently made changes to their positions in the stock. First Light Asset Management LLC increased its stake in shares of Streamline Health Solutions by 2.0% in the second quarter. First Light Asset Management LLC now owns 1,792,041 shares of the company’s stock valued at $2,150,000 after buying an additional 35,653 shares during the last quarter. Emerald Acquisition Ltd. purchased a new stake in shares of Streamline Health Solutions during the second quarter valued at approximately $211,000. Finally, Renaissance Technologies LLC increased its stake in shares of Streamline Health Solutions by 47.8% in the first quarter. Renaissance Technologies LLC now owns 116,200 shares of the company’s stock valued at $164,000 after buying an additional 37,583 shares during the last quarter. Hedge funds and other institutional investors own 43.60% of the company’s stock.
Streamline Health Solutions Company Profile
Streamline Health Solutions, Inc is engaged in providing healthcare information technology through the licensing of its Electronic Health Information Management, Patient Financial, Coding and Clinical Documentation Improvement (CDI), and other Workflow software applications, and the use of such applications by software as a service.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Streamline Health Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Streamline Health Solutions Inc. and related companies with MarketBeat.com's FREE daily email newsletter.